Direxion Daily S&P Biotech Bear 3X ETF
LABD
17 hedge funds and large institutions have $18.1M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
291% more call options, than puts
Call options by funds: $7.1M | Put options by funds: $1.81M
0.55% more ownership
Funds ownership: 1.33% → 1.88% (+0.55%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
18% less capital invested
Capital invested by funds: $22.1M → $18.1M (-$3.97M)
19% less funds holding
Funds holding: 21 → 17 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$4.58M |
| 2 |
VF
Virtu Financial
New York
|
+$3.78M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.03M |
| 4 |
TSS
Two Sigma Securities
New York
|
+$904K |
| 5 |
Jane Street
New York
|
+$456K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.63M |
| 2 |
BOCH
Blue Owl Capital Holdings
New York
|
-$3.57M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
-$2.55M |
| 4 |
ASM
AI-Squared Management
Hong Kong
|
-$1.38M |
| 5 |
Squarepoint
New York
|
-$733K |
LABD Hedge Fund Activity: Q2 2024 in Review
17 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q2 2024, worth a combined $18.1M — down 18% from $22.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LABD and 2 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $4.58M. The largest seller was Bank of America, cutting an estimated $4.63M.
- 17 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q2 2024, down from 21 in Q1 2024.
- Funds reported $18.1M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q2 2024, down 18% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q2 2024 and 6 closed out, a net change of -4 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q2 2024 was HRT Financial, an estimated $4.58M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q2 2024 was Bank of America, an estimated $4.63M sold.
Based on aggregated 13F filings for Q2 2024.